These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38953405)

  • 1. Functional decline among bullous pemphigoid patients: A retrospective monocentric cohort study.
    Ouakrat R; Peiffer B; David JP; Belmondo T; Sbidian E; Canouï-Poitrine F; Ingen-Housz-Oro S
    J Eur Acad Dermatol Venereol; 2024 Jul; ():. PubMed ID: 38953405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities of bullous pemphigoid: A single-center retrospective case-control study from Turkey.
    Kılıç Sayar S; Sun GP; Küçükoğlu R
    Dermatol Ther; 2021 Sep; 34(5):e15031. PubMed ID: 34137146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study.
    Wang SH; Shan Y; Li SZ; Zuo YG
    Front Immunol; 2023; 14():1165106. PubMed ID: 37545503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
    Masmoudi W; Vaillant M; Vassileva S; Patsatsi A; Quereux G; Moltrasio C; Abasq C; Prost-Squarcioni C; Kottler D; Kiritsi D; Litrowski N; Plantin P; Friedrichsen L; Zebrowska A; Duvert-Lehembre S; Hofmann S; Ferranti V; Jouen F; Joly P; Hebert V;
    Br J Dermatol; 2021 Jun; 184(6):1106-1112. PubMed ID: 33067805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
    Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
    Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients.
    Alexandre M; Bohelay G; Gille T; Le Roux-Villet C; Soued I; Morin F; Caux F; Grootenboer-Mignot S; Prost-Squarcioni C
    Front Immunol; 2022; 13():874108. PubMed ID: 35514989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Transient Palmoplantar Keratoderma With Clinical and Immunologic Characteristics of Bullous Pemphigoid.
    Duretz C; Antonicelli F; Muller C; Antonicelli N; Plee J; Viguier M; Bernard P
    JAMA Dermatol; 2019 Feb; 155(2):216-220. PubMed ID: 30484821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Bullous Pemphigoid: A Single-Center Retrospective Study.
    Moar A; Azzolini A; Tessari G; Schena D; Girolomoni G
    Dermatology; 2021; 237(6):1039-1045. PubMed ID: 33979792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of bullous pemphigoid with neuropsychiatric comorbidities is associated with anti-BP230 seropositivity.
    Ständer S; Hammers CM; Vorobyev A; Schmidt E; Hundt JE; Sadik CD; Lange T; Zillikens D; Ludwig RJ; Kridin K
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2067-2073. PubMed ID: 33896070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we predict functional decline in hospitalized older people admitted through the emergency department? Reanalysis of a predictive tool ten years after its conception.
    De Brauwer I; Cornette P; Boland B; Verschuren F; D'Hoore W
    BMC Geriatr; 2017 May; 17(1):105. PubMed ID: 28499358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid.
    Chen J; Mao X; Zhao W; Zhang B; Chen X; Yu C; Zheng Z; Jin H; Li L
    Front Immunol; 2020; 11():1607. PubMed ID: 32793235
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional decline in geriatric rehabilitation ward; is it ascribable to hospital acquired infection? A prospective cohort study.
    Laurent M; Oubaya N; David JP; Engels C; Canoui-Poitrine F; Corsin L; Liuu E; Audureau E; Bastuji-Garin S; Paillaud E
    BMC Geriatr; 2020 Oct; 20(1):433. PubMed ID: 33121435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Dupilumab in Patients With Bullous Pemphigoid.
    Zhao L; Wang Q; Liang G; Zhou Y; Yiu N; Yang B; Zhang G; Li W; Feng S; Shang P; Chen X; Zhu X; Zheng J; Pan M; Wang M
    JAMA Dermatol; 2023 Sep; 159(9):953-960. PubMed ID: 37531116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.
    Said JT; Liu M; Talia J; Singer SB; Semenov YR; Wei EX; Mostaghimi A; Nelson CA; Giobbie-Hurder A; LeBoeuf NR
    JAMA Dermatol; 2022 May; 158(5):552-557. PubMed ID: 35416925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls.
    Sim B; Fook-Chong S; Phoon YW; Koh HY; Thirumoorthy T; Pang SM; Lee HY
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1709-1714. PubMed ID: 28485892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgE anti-BP180 NC16A autoantibody in both serum and blister fluid samples does not correlate with disease activity of bullous pemphigoid.
    Sun C; Qian H; Liang G; Xiang R; Zhao C; Li Z; Suo L; Jing K; Wang Y; Zhang H; Li X; Feng S
    Eur J Dermatol; 2023 Dec; 33(6):595-603. PubMed ID: 38465539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230.
    Muhammed N; Korgaonkar S; Pradhan V; Khopkar US
    Indian Dermatol Online J; 2021; 12(5):696-700. PubMed ID: 34667755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.